Cite
HARVARD Citation
Crespo-Rodriguez, E. et al. (2020). Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. Journal for immunotherapy of cancer. 8 (2), p. . [Online].